Phase Bioscience

Phase Bioscience Inc., a Durham, N.C.-based biotherapeutics company, has secured the first tranche of its Series B funding from Johnson & Johnson Development Corp. and return backer Hatteras Venture Partners. No financial terms were disclosed. www.phasebio.com